Core Viewpoint - Salesforce, Inc. (NYSE:CRM) is recognized as a significant player in the AI sector, with analysts maintaining a positive outlook despite a price target reduction to $300 from $375, reflecting a strong buy rating [1][2]. Financial Summary - CFRA analysts have adjusted the 12-month price target to $300 based on a P/E ratio of approximately 21.3x the projected CY 27 EPS of $14.13, which is considered a substantial discount to historical averages [3]. - Following solid results for the July quarter, the FY 26 EPS estimate has been increased to $11.35 from $11.30, while FY 27 remains at $12.58, and FY 28 EPS is projected at $14.13 [3]. AI Integration and Market Position - Analysts believe that AI will enhance Salesforce's SaaS offerings rather than replace them, leveraging the company's access to enterprise data and solutions [4]. - A notable increase of 60% in customers transitioning from pilot to production for the Agentic AI offering indicates expanding use cases and scaling potential [4]. - The Agentic enterprise applications are expected to deliver significant productivity improvements and savings, which could lead to better monetization and pricing strategies [4]. Competitive Landscape - While Salesforce is viewed as a potential winner in the SaaS market amidst AI advancements, some analysts suggest that other AI stocks may present greater upside potential with less downside risk [5].
Why CFRA Remains Bullish on Salesforce (CRM) Despite Target Cut